Acetate Controls Endothelial-to-mesenchymal Transition
Xiaolong Zhu,Yunyun Wang,Ioana Soaita,Heon-Woo Lee,Hosung Bae,Nabil Boutagy,Anna Bostwick,Rong-Mo Zhang,Caitlyn Bowman,Yanying Xu,Sophie Trefely,Yu Chen,Lingfeng Qin,William Sessa,George Tellides,Cholsoon Jang,Nathaniel W. Snyder,Luyang Yu,Zoltan Arany,Michael Simons
DOI: https://doi.org/10.1016/j.cmet.2023.05.010
IF: 29
2023-01-01
Cell Metabolism
Abstract:Endothelial-to-mesenchymal transition (EndMT), a process initiated by activation of endothelial TGF-β signaling, underlies numerous chronic vascular diseases and fibrotic states. Once induced, EndMT leads to a further increase in TGF-β signaling, thus establishing a positive-feedback loop with EndMT leading to more EndMT. Although EndMT is understood at the cellular level, the molecular basis of TGF-β-driven EndMT induction and persistence remains largely unknown. Here, we show that metabolic modulation of the endothelium, triggered by atypical production of acetate from glucose, underlies TGF-β-driven EndMT. Induction of EndMT suppresses the expression of the enzyme PDK4, which leads to an increase in ACSS2-dependent Ac-CoA synthesis from pyruvate-derived acetate. This increased Ac-CoA production results in acetylation of the TGF-β receptor ALK5 and SMADs 2 and 4 leading to activation and long-term stabilization of TGF-β signaling. Our results establish the metabolic basis of EndMT persistence and unveil novel targets, such as ACSS2, for the potential treatment of chronic vascular diseases.